Regeneron Pharmaceuticals
Regeneron is seeking 2027 Summer Interns for its Combination Products & Device Development organization within Regeneron Industrial Operations and Product Supply (IOPS). Interns will work onsite in Rensselaer, NY, from May/June through August, contributing to the design, testing, and validation of medicine delivery devices like prefilled syringes and auto-injectors. The role offers a chance to support a science-driven team making a meaningful impact on patient care worldwide.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
15% below the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Senior Engineer/Manager, Device Development — Combination Products
Oruka Therapeutics
Associate Engineering Director, Combination Drug Product/Device
Neurocrine Biosciences
Technical Lead and Subject Matter Expert for Combination Products and Drug Delivery Devices
Scholar Rock
Engineer, Device Development
Viking Therapeutics
Director, Combination Product & Device Development
Jade Biosciences
Principal Device Engineer
Teva Pharmaceutical